Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 330

2.

Impaired catabolism of very low-density lipoprotein-triglyceride in a family with primary hypertriglyceridemia.

Dunn FL, Grundy SM, Bilheimer DW, Havel RJ, Raskin P.

Metabolism. 1985 Apr;34(4):316-24.

PMID:
3884962
4.
5.

Differential effect of fenofibrate and atorvastatin on in vivo kinetics of apolipoproteins B-100 and B-48 in subjects with type 2 diabetes mellitus with marked hypertriglyceridemia.

Hogue JC, Lamarche B, Deshaies Y, Tremblay AJ, Bergeron J, Gagné C, Couture P.

Metabolism. 2008 Feb;57(2):246-54. doi: 10.1016/j.metabol.2007.09.008.

PMID:
18191056
6.

Effects of fish oil on VLDL triglyceride kinetics in humans.

Harris WS, Connor WE, Illingworth DR, Rothrock DW, Foster DM.

J Lipid Res. 1990 Sep;31(9):1549-58.

7.
9.

Triglyceride and cholesterol metabolism in primary hypertriglyceridemia.

Beil U, Grundy SM, Crouse JR, Zech L.

Arteriosclerosis. 1982 Jan-Feb;2(1):44-57.

10.

Comparison of clofibrate and caloric restriction on kinetics of very low density lipoprotein triglycerides.

Kesaniemi YA, Beltz WF, Grundy SM.

Arteriosclerosis. 1985 Mar-Apr;5(2):153-61.

11.

Apolipoprotein CIII deficiency prevents the development of hypertriglyceridemia in streptozotocin-induced diabetic mice.

Takahashi T, Hirano T, Okada K, Adachi M.

Metabolism. 2003 Oct;52(10):1354-9.

PMID:
14564689
12.

Studied of very low density lipoprotein triglyceride metabolism in an obese population with low plasma lipids: lack of influence of body weight or plasma insulin.

Howard BV, Zech L, Davis M, Bennion LJ, Savage PJ, Nagulesparan M, Bilheimer D, Bennett PH, Grundy SM.

J Lipid Res. 1980 Nov;21(8):1032-41.

13.

Plasma low density lipoprotein transport kinetics in noninsulin-dependent diabetes mellitus.

Kissebah AH, Alfarsi S, Evans DJ, Adams PW.

J Clin Invest. 1983 Mar;71(3):655-67.

15.

Effect of atorvastatin on apolipoprotein B100 containing lipoprotein metabolism in type-2 diabetes.

Ouguerram K, Magot T, Zaïr Y, Marchini JS, Charbonnel B, Laouenan H, Krempf M.

J Pharmacol Exp Ther. 2003 Jul;306(1):332-7. Epub 2003 Apr 8.

16.

Structural peculiarities of the binding of very low density lipoproteins and low density lipoproteins to the LDL receptor in hypertriglyceridemia: role of apolipoprotein E.

Dergunov AD, Smirnova EA, Merched A, Visvikis S, Siest G, Yakushkin VV, Tsibulsky V.

Biochim Biophys Acta. 2000 Feb 24;1484(1):29-40.

PMID:
10685028
17.

Glibenclamide improves postprandial hypertriglyceridaemia in type 2 diabetic patients by reducing chylomicrons but not the very low-density lipoprotein subfraction levels.

Skrapari I, Perrea D, Ioannidis I, Karabina SA, Elisaf M, Tselepis AD, Karagiannacos P, Katsilambros N.

Diabet Med. 2001 Oct;18(10):781-5.

PMID:
11678967
18.
19.

Biotin supplementation reduces plasma triacylglycerol and VLDL in type 2 diabetic patients and in nondiabetic subjects with hypertriglyceridemia.

Revilla-Monsalve C, Zendejas-Ruiz I, Islas-Andrade S, Báez-Saldaña A, Palomino-Garibay MA, Hernández-Quiróz PM, Fernandez-Mejia C.

Biomed Pharmacother. 2006 May;60(4):182-5. Epub 2006 Mar 31.

PMID:
16677798
20.

Suppression by diets rich in fish oil of very low density lipoprotein production in man.

Nestel PJ, Connor WE, Reardon MF, Connor S, Wong S, Boston R.

J Clin Invest. 1984 Jul;74(1):82-9.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk